They showed that EPC administration decreased M1 pro-inflammatory microglia, as seen by a decrease in major histocompatibility complex (MHC) class II + staining in the cortex and the striatum 7 days after stroke [26]. The gene discussed is HLA-C; the disease is stroke disorder.